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Susceptibility to infection by the human immunodeficiency virus type-1 (HIV-1), both in vitro and in vivo, requires
the interaction between its envelope (Env) glycoprotein gp120 Env and the primary receptor (R), CD4, and Co-R,
either CCR5 or CXCR4, members of the chemokine receptor family. CCR5-dependent (R5) viruses are responsible for
both inter-individual transmission and for sustaining the viral pandemics, while CXCR4-using viruses, usually dual-
tropic R5X4, emerge in ca. 50% of individuals only in the late, immunologically suppressed stage of disease. The
hypothesis that such a major biological asymmetry is explained exclusively by the availability of cells expressing
CCR5 or CXCR4 is challenged by several evidences. In this regard, binding of the HIV-1 gp120 Env to the entry R
complex, i.e. CD4 and a chemokine R, leads to two major events: virion-cell membrane fusion and a cascade of cell
signaling. While the fusion/entry process has been well defined, the role of R/Co-R signaling in the HIV-1 life cycle
has been less characterized. Indeed, depending on the cellular model studied, the capacity of HIV-1 to trigger a
flow of events favoring either its own latency or replication remains a debated issue. In this article, we will review




Infection with the human immunodeficiency virus 1 type-
1 (HIV-1) causes a severe and selective depletion of the
CD4
+ T lymphocytes both in vivo and in vitro.S u c ha
selective tropism and pathogenicity of the virus immedi-
ately suggested an important involvement of the CD4
molecule in the infectious process. In 1984, CD4 was
described as main receptor (R) for HIV-1 entry into this
subset of T lymphocytes [1-3]. Later on, CD4 was also
demonstrated to be the main entry R for the virus in
mononuclear phagocytes and dendritic cells (DC),
although not in astrocytes of the central nervous system
[4]. However, the requirement for one or more essential
cofactor(s) or Co-R in addition to CD4 for allowing HIV-1
(and HIV-2) entry in target cells emerged rapidly by stu-
dies in which non-human cells transfected with human
CD4, although capable of binding HIV-1 virions, were not
permissive to HIV infection and replication [5-7].
After a decade of research and “false alarms” two
7-transmembrane domain G protein-coupled R belonging
to the chemokine R family, i.e. CXCR4 and CCR5, were
sequentially identified as the missing cell surface factors
conferring competence for entry and replication of the
virus into CD4
+ cells [5,8-11]. Viruses were then
classified as R5, X4 or “dualtropic” R5X4 depending on
which Co-R they used to infect non-human cells trans-
fected with human CD4 and a panel of human chemo-
kine R, including CCR2 and CCR3, rarely used in vivo
[12]. R5 viruses were soon demonstrated to be responsi-
ble for both inter-individual transmission, regardless of
the route of transmission (i.e., sexual, systemic, mother-
to-child), and for sustaining the pandemics, whereas
CXCR4-using viruses, usually dualtropic R5X4, emerge in
ca. 50% of individuals in the late, immunologically sup-
pressed stage of disease. Fuerthermore, such a “switch”
in Co-R usage (that should be more correctly referred to
as an extension in most cases) almost exclusively occurs
in individuals infected with subtype B viruses, dominant
in North America, Europe and Australia [13]. However, a
superior cytopathicity of CXCR4-using viruses is well
demonstrated and results in an accelerated progression
to AIDS and death if the infection is not halted by anti-
retroviral therapy (ART) [13,14].
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of whether such a disproportionate asymmetry in HIV-1
Co-R use is exclusively determined at the virion entry
level by availability of CCR5 vs. CXCR4 expression on
the surface of CD4
+ cells or whether R/Co-R mediated
signaling also influences the capacity of the virus to effi-
ciently replicate in its own target cells. In this regard,
the viral entry step in the retroviral life cycle was
demonstrated not to be dependent upon G-coupled R
signaling since mutations in CCR5 ablating its signal
transduction capacity did not affect its Co-R activity in
transfected cells [15,16]. However, triggering of chemo-
kine signaling could potentially contribute to viral repli-
cation at a post-entry level, for example by promoting
or repressing proviral transcription. This article will
briefly overview what has been learned on this second
potential function of CCR5 vs. CXCR4 in CD4
+ T
lymphocytes.
Co-R expression and state of activation in
peripheral blood and lymphoid tissue associated
CD4
+ T lymphocytes
From the bone marrow, T lymphocyte precursors reach
the thymus where they become terminally differentiated
into CD4
+ and CD8
+ T cells and are then exported into
the bloodstream [17]. Concerning the expression of HIV-
1 Co-R in thymocytes, CXCR4 is abundantly expressed
by both thymocytes and epithelial cells while CCR5 is
detected only on a minority of mature thymocytes, as
reviewed in [18]. Yet, although X4 infection and cyto-
pathicity of thymocytes clearly occurs, R5 viruses can
infect and replicate efficiently in this organ [18].
Phenotypically, peripheral blood naïve T cells are
characterized by the surface expression of three key
molecules: the RA isoform of the CD45 antigen, the
L-selectin ligand (CD62L) and CCR7, a chemokine R
[19,20]. Immature DC, like Langherans’cells in the skin,
express CCR7 and can therefore migrate, like T cells, to
the lymph nodes in response to CCR7L, CCL19 and
CCL21, expressed by lymph nodes associated cells.
Memory T cells can be divided into central memory
(TCM) and effector memory (TEM) cells distinct for phe-
notypic and functional properties [21]. In particular,
human TCM are CD45RO
+ and constitutively express
CCR7 and CD62L that are required for cell extravasa-
tion through high endothelial venules and migration to
T cell areas of secondary lymphoid organs [19,20]. In
contrast, human TEM have lost the constitutive expres-
sion of CCR7, are heterogeneous for CD62L expression,
and display characteristic sets of chemokine R and adhe-
sion molecules required for homing to inflamed tissues
[21]. The levels or cell surface density of both CD4 and
HIV Co-R in these different subsets of T cells may play
a significant role in the efficiency of virion-cell
membrane fusion and, consequently, their susceptibility
to infection [22].
The importance of the density of CD4 and Co-R for
HIV infection was investigated also in cell types differ-
ent than T cells. In HeLa-CD4/CCR5 cells stably expres-
sing minimal concentrations of CCR5 on the cell surface
R5 HIV-1 infection occurred more efficiently in conco-
mitance of “high” levels of CD4 expression, suggesting
that a minimal number of CCR5 molecules are required
when cell surface levels of CD4 reach a sufficient density
[22]. At lower CD4 concentrations, higher numbers of
CCR5 molecules were indeed necessary to achieve the
same high efficiency of viral replication [22]. In this
regard, the levels of CD4 and Co-R expression in per-
ipheral blood T cells can vary from 2- to 5-folds among
different donors and also depend on the activation sta-
tus of the cells. CXCR4 is usually expressed by a higher
fraction of CD4
+ T lymphocytes than CCR5; conversely,
the levels of CCR5 expression on the cells that stain
positive for this chemokine R are usually 2-3 fold
greater than those of CXCR4 [23]. In addition, HIV-1
has been shown to deplete preferentially HIV-specific
CD4
+ T cells, likely via a “double kiss” through the
CD4/Co-R complex facilitated by the virological synapse
established by T cell receptor (TCR)/MHC class II inter-
action with viral peptides expressed by the infected cells
[24]. Thus, it is difficult to decipher the dynamics of
HIV-1 in infected individuals simply on the basis of
CCR5 and CXCR4 expression on CD4
+ T cells.
CCR5 is expressed preferentially by the CD45RO
+
subset of TEM,w h e r e a sC X C R 4i sm o r ed e n s eo nt h e
surface of naïve CD45RA
+ T cells [25]. Activated/mem-
ory T cells can traffic to peripheral lymphoid organs at
mucosal surfaces and form conjugates with DC or
macrophages at these sites [26], thus representing early
targets for infection and spreading of R5 viruses [27].
Although naïve T cells show lower levels of CCR5
expression and higher levels of CXCR4 in comparison
to memory cells [25], they were shown to possess a
higher in vitro susceptibility to R5 HIV-1 infection than
memory T cells following stimulation with immobilized
anti-CD3 plus anti-CD28 Ab. This paradoxical observa-
tion was explained by the higher capacity of memory T
cells to secrete CCR5 ligands, i.e CCL3, CCL4 and
CCL5, acting as antagonists of HIV-1 infection, follow-
ing TCR cell stimulation [28]. In addition, CD4
+ Tc e l l
activation by anti-CD3 plus anti-CD28 immobilized Ab
induced a downregulation of CCR5 while enhancing
secretion of its ligands [29-31]. Furthermore, sustained
CD28 signaling, as well as IL-4 [32,33], can upregulate
the expression of CXCR4 and, consequently, favor X4
HIV-1 infection and replication in activated T cells [34].
Conversely, IL-2 stimulation of T cells was shown to
induce an increased expression of CCR5 concomitantly
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expression by T cells resulted in increased secretion of
CCR5 ligands by macrophages and DC with selective
inhibition of R5, but not of X4 HIV-1 infection [35].
Concerning tissue-associated CD4
+ T lymphocytes, X4
HIV-1 replication was earlier shown to be more efficient
than that of R5 viruses in suspensions of human lym-
phoid tissue [36]. This observation was confirmed in
histological cultures of lympoid tissue blocks (a biologi-
cal system that maintains, at least in part, the integrity
of the lymphoid organs therefore better reflecting the
in vivo situation than cell suspension of meshed tissue)
and was correlated to a higher percentage of CXCR4
+
cells vs. CCR5
+ cells as well as to the “constitutive” pro-
d u c t i o no fC C R 5l i g a n d s[ 37]. In later studies by the
Margolis’ team, both rectosigmoidal and cervico-vaginal
tissues were shown to be more prone than tonsillar tis-
sue to R5 infection likely because of the high prevalence
of R5 targets and a reduced chemokine production and
R blockade [38,39]. Additional evidence that X4 HIV-1
can replicate with higher efficiency than R5 in both cord
blood- and adult-derived PBMC was also reported [40].
In contrast, Yamamoto and colleagues suggested that a
selective spreading of R5 vs. X4 HIV-1 occurred in the
context of DC-T cell co-cultures. The superior efficiency
of R5 vs. X4 viruses in DC-T cell spreading was shown
to be dependent upon the state of activation of CD4
+ T
cells and not consequent of a higher efficiency by virus
to infect DC [41] (Table 1). In this regard, R5 HIV-1
replicated more efficiently than the X4 viruses in periph-
eral blood derived primary CD4
+ T cells expressing
in vivo levels of CCR5 on their surface [42]. In particu-
lar, Fiser and colleagues showed that CCR5 expression
did not vary significantly with time in primary CD4
+ T
cells maintained in culture in the absence of stimuli.
This was in contrast to CXCR4 density that increased
by 10 fold after 24 h of culture likely consequently to
the absence of CXCL12-dependent CXCR4 internaliza-
tion [42]. Indeed, when lymphocytes were co-cultivated
with 293T cells transduced with a lentiviral vector
expressing CXCL12, the R5 HIV-1 replicated more effi-
ciently than the X4 virus [42].
Thus, depending on the in vitro stimulation of CD4
+
T cells, the susceptibility to R5 and X4 HIV-1 infection
can vary. In particular, R5 viruses appear to possess a
superior replicative capacity than X4 HIV in homeo-
static conditions (i.e. low cell activation status and
in vivo levels of the respective chemokine R), whereas a
sustained and prolonged in vitro T cell activation lead-
ing to the overexpression of CXCR4 on cellular surface
tilts the balance in favor of X4 viruses in terms of repli-
cative potential.




+ T lymphocytes may undergo functionally distinct
programs of polarized activation and differentiation,
defined as Th1/Th2 (or type 1/type 2) T cell helper
pathways reflecting a preferential activation of cell-
mediated vs. humoral immunity, respectively [43]. In
regard to HIV infection, a shift from Th1 to Th0/Th2
mediated immune response has been early postulated as
crucial determinant of both the susceptibility of most
individuals to infection and of the progression of disease
[44] by analogy with the dichotomous roles played by
polarized immune responses in parasite infection [45].
Table 1 Controversial results on the capacity of R5 vs. X4 HIV-1 to replicate in primary CD4+ T lymphocytes in vitro
CELL TYPE STIMULATORY CONDITIONS KEY REFERENCES
X4=R5
Lymphoid histo-cultures none Grivel et al. (40)
X4>R5
Lymphocyte tissue suspensions none Eckstein et al. (38)
Cord blood CD4
+ T cells PHA+IL-2 Sundaravaradan et al. (42)
PBMC-derived Th2 cell clones Anti-CD3 mAb or Der P1+ IL-2 Maggi et al. (51) Annunziato et al. (52)
PBMC-derived Th2 cells Anti-CD3+anti-CD28 mAb Gosselin et al. (54)
R5>X4
PBMC-derived CD4
+ T cells none Fiser et al. (44)
PBMC-derived Th1 cell clones Anti-CD3 mAb or Der P1+ IL-2 Maggi et al. (51) Annunziato et al. (52)
Cord blood derived Th0, Th1, Th2 cells Anti-CD3 mAb + IL-2 Vicenzi et al. (55)
PBMC-derived Th1 and Th2 cell clones Anti-CD3 mAb+ IL-2 Vicenzi et al. (55)
PBMC-derived CD4
+ T cells co-cultured with DC Anti-CD3+anti-CD28 mAb Yamamoto et al. (43)
Naïve and memory peripheral T cells None Bleul (25)
Recto-signoidal histocultures None Grivel et al. (40)
Cervico-vaginal histocultures Culture medium Saba et al. (41)
* after normalization per number of CCR5 vs. CXCR4 expressing cells.
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was associated with Th1 and Th2 cells; in particular,
CXCR3, CCR1 and CCR5 were related to Th1 polariza-
tion while CXCR4, CCR3 and CCR4 expression was
associated with Th2 cells [46].
CCR5 is almost undetectable in resting T cells,
although it is promptly upregulated on the surface of
Th1 cells by the related cytokines IL-12 and IFN-g
[46-48]. Conversely, CCR5 was shown to be downregu-
lated by the Th2 cytokine IL-4 that, in contrast, upregu-
lated CXCR4 expression on the surface of both Th2
cells and other cell types [32,33]. Annunziato et al.
reported that acute infection of Th1 and Th2 cells
indeed reflected the predictable pattern of differential
HIV-1 Co-R expression, with Th1 and Th2 cells sup-
porting efficiently R5 and X4 virus replication, respec-
tively, although Th1 cells were reported to limit R5
HIV-1 spreading via upregulated secretion of CCR5
binding chemokines [49-51]. However, this study was
focused on the early kinetics of HIV-1 replication during
the first week of infection. More recently, Th1 cells have
been described as expressing CXCR3, CCR5 and
CXCR4 but not CCR6 and being relatively resistant to
R5 and X4 HIV in vitro [52]. In the same study, Th2
cells were shown to express CCR4, but not CCR6 or
CCR5, and were permissive to X4 HIV only [52].
An earlier study from our group looked at both polar-
ized and unpolarized T cells of different origin, includ-
ing classical Th1, Th2 or Th0 (unpolarized) T cell
clones originated from adults peripheral blood or non-
immortalized T cell lines derived from cord blood cells
(particularly rich in naïve T cells) maintained for 14-20
days after polarization in medium containing IL-2 before
exposure to R5 or X4 HIV-1. We have earlier observed
that only R5, but not X4, HIV-1 efficiently replicated in
both polarized and unpolarized T cell lines or clones in
the face of the higher levels of expression of CXCR4
observed particularly in Th2 cells [53]. The lack of X4
HIV replication was not sustained by endogenous
expression of CXCL12 and was reproduced with viruses
derived from infectious molecular clones (pNLA4-3 and
pNL-Ad8) sharing the same backbone except for the
env-coding region, X4 and R5, respectively [53]. Of
interest was the fact that infection by both R5 and X4
HIV-1 occurred with comparable efficiency in these pri-
mary cells up to 72 h post-infection when R5 viruses
began to spread with an approximately 100-fold higher
efficiency than X4 viruses [53]. However, re-stimulation
of infected T cells by anti-CD3 mAb showed a dichoto-
mous effect on R5 and X4 infections in that, on the one
hand, strongly induced X4 HIV-1 replication, while, on
the other hand, did not affect significantly the already
efficient capacity of R5 viruses to propagate in these T
cells [53]. We interpreted these results as suggestive of a
superior capacity of CCR5 in delivering a cell-activating
signal required for efficient HIV-1 spreading in T cells
that is lacking when the cells are infected with an X4
virus (Figure 1). This interpretation is supported by ear-
lier evidence showing that R5 gp120 Env trimers can
deliver a qualitatively or quantitatively different signal to
T cells resulting in Ca
++-dependent signaling [54-56], as
reviewed elsewhere in this issue. Indeed, Ca
++-depen-
dent signaling was earlier shown in different model sys-
tems to activate HIV expression in chronically infected
cells [57] (Figure 2).
Concerning the novel subset of Th17 cells, which play
a beneficial role in immunity against bacteria and fungi
and contribute to the pathogenesis of autoimmune dis-
eases, it has recently been shown that they are charac-
terized by co-expression of CCR4 and CCR6 [52,58]. In
addition, they express both CCR5 and CXCR4 therefore
being permissive to R5 and X4 HIV replication, as
reviewed in ref [59].
Although CD4
+ T regulatory cells (Tregs) are believed
to play an important role in HIV pathogenesis [60], as
illustrated by their involvement in the immune response
in the apathogenic model of African Green Monkeys to
SIV infection [61] as well as in pathogenic SIV infection
of macaques by FoxP3+ CD8+ T cells [62], no specific
studies have been designed to address their potential
role in R5 vs. CXCR4-dependent HIV-1 infection.
The observation that R5 viruses are endowed with a
higher capacity to replicate in CD4
+ T cells than X4
viruses, together with their ability to replicate in mono-
nuclear phagocytes [63], provides a potential correlation
of their superior capacity of establishing a productive
infection after viral transmission and during the asymp-
tomatic stage of disease.
CD4/Chemokine Co-R signaling in HIV infection
The sequential interaction between gp120 Env with CD4
and the chemokine R triggers different cell activation
signals. In particular, the interaction of HIV-1 with
CCR5 leads to the phosphorylation of the focal adhesion
kinase, of CCR5 itself as well as of their association [64],
activation of ion channels [56], Ca
++ mobilization [54],
tyrosine (Tyr) phosphorylation of the Tyr kinase Pyk2
[65], downregulation of intracellular cAMP [66], and
induction of chemotaxis [55]. CCR5 signaling has also
been known to trigger distinctive signaling cascades that
activate kinases and transcription factors associated with
cell activation [67,68]. For example, R5 gp120 Env can
induce the expression of genes either belonging to Mito-
gen-Activated Protein Kinase (MAPK) pathways and
others regulating the cell cycle [68]. R5 gp120 Env can
also activate members belonging to the Nuclear Factor
of Activated T-Cells (NFAT) family of transcription fac-
tors and induce their translocation to the nucleus [69],
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moter. Moreover, the interaction of X4 viruses with
CXCR4 leads to the activation of an actin-depolymeriza-
tion factor, cofilin, that increase the cortical actin
dynamics in resting CD4
+ T cells, leading to HIV repli-
cation [70] (Figure 2).
The direct involvement of chemokine Co-R signaling
in HIV-1 infection has been investigated soon after the
identification of CXCR4 and CCR5 as obligatory entry
Co-R. Cocchi and colleagues reported that inhibition of
Co-R signaling through pertussis toxin (PTX) neither
inhibited HIV-1 replication nor the ability of chemo-
k i n e ss u c ha sC C L 5t ob l o c kH I V - 1e n t r yi n t oP M 1
cells [15]. However, this phenotype was likely due to the
unresponsiveness of this cell line to PTX (M. Alfano,
personal communication). Both PTX and its oligomeric
nontoxic derivative PTX-B were actually shown to be
potent inhibitors of R5 HIV-1 entry as well as of both
R5 and X4 virus replication in different target cells,
including primary T and macrophage cells, secondary
lymphoid histocultures and acutely or chronically
infected cell lines [71,72].
T h r e eC C R 5m u t a n t so ft h eh i g h l yc o n s e r v e dA s p -
Arg-Tyr (DRY) motif in the second intracellular loop
were required for agonist-induced CCR5 activation, but
showed minimal effects on viral entry and replication in
Hela-CD4 cells [16]. Similar mutations in CXCR4 also
failed to affect its Co-R capacity in vitro [73]. Moreover,
expression of either WT or signaling-deficient CCR5
molecules by lentivirus-mediated gene transfer into pri-
mary T cells and macrophages from ccr5Δ32 homozy-
gous individuals resulted in comparable efficiency of
virus replication [74], supporting the concept that sig-
naling via CCR5 or CXCR4 was not required for viral
entry and, accordingly to at least some authors, replica-
tion into host cells.
In contrast, several studies have provided evidence for
an important role of gp120 Env-mediated signaling in
HIV-1 replication. By avoiding mitogen-dependent pre-
activation of T cells, G-protein signaling triggered dur-
ing R5 infection significantly facilitated virus replication
in primary CD4
+ T cells [75]. Similarly, IL-2 stimulation
of PBMC in the absence of mitogen pre-stimulation




















Figure 1 HIV-1 replication and co-receptor use in naive, memory and Th subsets. Both Naive and Th2 cells are characterized by high level
of CXCR4 expression that is upregulated by IL-4. Memory and Th1 cells show surface levels of CCR5 higher than those of CXCR4, whereas Th17
cells express both Co-R.
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monocyte-dependent manner [76]. Moreover, stimula-
tion with viral gp120 trimers triggered virus replication
in cultures of resting CD4
+ T cells of infected indivi-
duals [77]. In particular, a direct correlation was
observed between the capacity of gp120 Env to initiate
signaling and the ability of the virus to replicate in the
cells [54]. Furthermore, a signaling-deficient R5 HIV-1
entered monocyte-derived macrophages (MDM) but
failed to replicate because of a block occurring at a
post-entry level [54]. Before this study, Popik and collea-
gues, using a monomeric gp120 Env, demonstrated that
binding of HIV-1 to CD4 in T cells activates the
MAPK/extracellular signal-regulated kinase (MEK) path-
way, stimulates the activation of transcription factors (i.
e., AP-1, NF-B and C/EBP) with consequent expression
of inflammatory genes [78]. This study also showed that
triggering of this signaling pathway was independent of
HIV-1 binding to the chemokine R in that could be
induced in CD4
+ cells by both X4 and R5 viruses [78].
A new family of chemokine inhibitors capable of
blocking chemokine R signaling without affecting R
binding, termed Broad Spectrum Chemokine Inhibitors
(BSCI), was recently described [79]. BSCI blocked HIV-
1 replication, without inhibiting gp120 Env interaction
with CCR5 or CXCR4 in THP-1 monocytic and Jurkat
T lymphocytic cell lines, respectively [79]. These find-
ings together suggest that although chemokine Co-R sig-
naling is not required for the efficient entry of R5 and
X4 viruses into target cells, it likely plays an important
role in order to guarantee efficient virus replication by
affecting one or more post-entry steps in the virus life
cycle. Indeed, CCR5 ligation might trigger a series of
events that could influence cell survival or cell death. In
this regard, engagement of CCR5 human monocytes by






















Figure 2 Differential cell activation pathways triggered by R5 and X4 HIV-1 in CD4
+ T cell. Both R5 and X4 HIV-1 gp120 Env engagement
of CD4 and Co-R trigger signal transduction events leading to cell activation, host gene transcription, cell migration, survival and adhesion.
R5 HIV-1 specifically induces adhesion via activation of FAK whereas X4 viruses modulate actin dynamics via activation of cofilin.
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apoptosis [80]. However, no studies has yet determined
whether CXCR4 signaling can also confer resistance to
apoptosis in monocyte/macrophages independently of
immune activation.
Conclusion
Although a definitive model explaining the differential
capacity of R5 and X4 viruses to replicate in CD4
+ lym-
phocytes cannot be still drawn, it is important that the
search for correlates of such a relevant difference
between these two amazingly similar pathogens with so
different outcomes for human health (if HIV-1 could
only rely on CXCR4 the infection and disease would
likely be much more contained and preventable) will
still continue.
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